United States

Deinove SA (ALDEI.PA)

ALDEI.PA on Paris Stock Exchange

8:40am EDT
Change (% chg)

€-0.04 (-2.13%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Deinove to list 260,000 new ordinary shares - Euronext
Monday, 5 Dec 2016 08:00am EST 

Euronext: Deinove SA to list 260,000 new ordinary shares, immediately assimilated with the existing ordinary shares, on alternext paris as of December 7 . Reason Deinove capital increase is exercise of non listed stock warrant Further company coverage: [ALDEI.PA] (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;)).  Full Article

Deinove receives 10 new patent grant agreements​​
Thursday, 18 Feb 2016 01:00pm EST 

Deinove SA:R‍eceives from US agreement for issuance of its patent PF7​.Also receives nine grants on other patent families.  Full Article

Deinove raises 10.7 mln euros in capital increase
Monday, 21 Dec 2015 02:44am EST 

Deinove SA:Total demand of about 11.8 million euros in capital increase, reflecting oversubscription rate of 128 pct of offer​‍.Full exercise of extension clause bringing issue size to 10.7 mln euros​.‍1,873,590 new shares subscribed on irreducible basis, representing about 90.9 pct of new shares to be issued​.‍After full exercise of extension clause, total gross proceeds of transaction amounts to 10.7 mln euros, issue premium included​.‍Share capital, following capital increase, to amount to 3.4 million euros​.‍Reducible subscriptions amounted to 759,178 new shares and is to be, as a result, satisfied only in part, i.e. for 497,046 new shares.  Full Article

Deinove announces capital increase of about 9.3 mln euros
Friday, 27 Nov 2015 01:41am EST 

Deinove SA:Announces capital increase, with shareholders' preferential subscription rights, of about 9.3 mln euros to finance its new momentum and industrialize its bioprocesses.Subscription parity is one new share for three existing shares.Subscription price is 4.50 euros per share.Subscription period to last from Nov. 30 to Dec. 14 inclusive.Subscription commitments are 5.5 mln euros.Says proceeds of issue will be used to give company financial means to finance acceleration of its development and industrialization of its bioprocesses, both in biofuels and biochemical.  Full Article

Deinove successfully reaches 2G bioethanol pre-industral scale in a 300-liter fermenter
Thursday, 19 Nov 2015 12:30pm EST 

Deinove SA:Deinove successfully reaches 2G bioethanol pre-industral scale in a 300-liter fermenter.Is confident in capabilities to provide a technological and economically competitive solution by 2018.  Full Article

Deinove obtains six new US patents
Thursday, 12 Nov 2015 01:30pm EST 

Deinove SA:Deinove obtains six new US patents.  Full Article

Deinove announces new R&D project with Flint Hills Resources
Tuesday, 3 Nov 2015 12:30pm EST 

Deinove SA:Announces a new research and development project in animal nutrition with Flint Hills Resources.  Full Article

Deinove provides update regarding its carotenoids strategy
Monday, 26 Oct 2015 01:30pm EDT 

Deinove SA:Provides update regarding its carotenoids production strategy.Announces start of operations for manufacturing of first batches of deinoxanthin by POS Bio-Sciences.Initiates regulatory approval process of its strains, particularly in US.Trust that first batch of carotenoids can be marketed within two to three years.  Full Article

Deinove SA and Tyton BioEnergy Systems Forge Partnership to Commercialize Unique Solutions in the Green Chemicals Sector
Tuesday, 8 Sep 2015 02:00am EDT 

Deinove SA and Tyton BioEnergy Systems:Says that they have entered into a technological and commercial partnership.The main goal of the partnership is to combine Tyton`s energy tobacco feedstock, process and production infrastructure with DEINOVE`s Deino-based fermentation solutions in order to produce green chemical compounds of high commercial value.  Full Article

Deinove SA produces muconic acid from 2G Substrates
Wednesday, 2 Sep 2015 02:00am EDT 

Deinove SA:announces that they have produced muconic acid in their laboratory using second-generation substrates.  Full Article

More From Around the Web